Herbert Smith Freehills Kramer advises the sole sponsor on HJ Science’s Hong Kong IPO

HJ Science is a clinical-stage biotech company focused on the research and development of therapies for autoimmune, metabolic and oncology diseases.

from Google Alert – international law https://ift.tt/ZLm0Kor
June 24, 2026 at 08:58AM